Andrew S Allegretti
15PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 31, 2025
Real-World Indirect Treatment Comparison of Terlipressin vs Midodrine Plus Octreotide in Hepatorenal Syndrome-Acute Kidney Injury.Stevan A Gonzalez, Andrew S Allegretti, Viktor V Chirikov
|Jul 14, 2025
Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial.Andrew S Allegretti, Josh Levitsky, Pratima Sharma
|Mar 07, 2025
The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis.Giuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar
|Nov 15, 2024
Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment.Ignacio Portales-Castillo, Rhea Singal, Anastasia Ambrose
|May 30, 2024
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis.Mohammad Amin Fallahzadeh, Andrew S Allegretti, Mitra K Nadim
|Mar 27, 2024
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?Eric M Przybyszewski, Robert M Wilechansky, Paige McLean Diaz
Pageof 3
Frequent Collaborators
4 joint publications
Giuseppe Cullaro
4 joint publications
Kavish R Patidar
2 joint publications
Salvatore Piano
2 joint publications
Juan Carlos Q Velez
2 joint publications
Sumeet K Asrani
2 joint publications
Eric S Orman
1 joint publications
Neal B Shah
1 joint publications
Douglas A Simonetto
1 joint publications
Alessio Fasano
1 joint publications
Claire Francoz
